Jade Biosciences, Inc. (JBIO) Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference Prepared Remarks Transcript [Seeking Alpha]
Jade Biosciences, Inc. (JBIO)
Company Research
Source: Seeking Alpha
Tom Frohlich - CEO & Director Conference Call Participants Trevor Allred - Oppenheimer & Co. Inc., Research Division Presentation Trevor Allred Oppenheimer & Co. Inc., Research Division Good morning, everybody, and welcome to another presentation with the Oppenheimer Life Sciences Conference. I'm Trevor Allred, an analyst here with the Oppenheimer Life Sciences team. We have with us today Tom Frohlich, CEO at Jade Bio. Tom, please take it away. Tom Frohlich CEO & Director Great. Thanks, Trevor. Much appreciated, and thanks to the Oppenheimer organization for hosting us. It's been a really great conference. And I'm very pleased to provide an overview of Jade Biosciences on behalf of our team. As always, I'll be making forward-looking statements. So for more details, please do look at our SEC filings. Jade Biosciences is a company really dedicated to developing best-in-class therapeutics across a number of different autoimmune diseases. We have been established wi
Show less
Read more
Impact Snapshot
Event Time:
JBIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JBIO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JBIO alerts
High impacting Jade Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
JBIO
News
- Jade Biosciences Touts “Best-in-Class” Autoimmune Antibodies, JADE101 Phase 1 Readout Nears [Yahoo! Finance]Yahoo! Finance
- Jade Biosciences to Participate in Upcoming Conferences [Yahoo! Finance]Yahoo! Finance
- Jade Biosciences to Participate in Upcoming ConferencesGlobeNewswire
- H.C. Wainwright Initiates Jade Biosciences (JBIO) at Buy With $25 PT as JADE101 Eyes $926M Peak Revenue [Yahoo! Finance]Yahoo! Finance
- Jade Biosciences (NASDAQ:JBIO) was upgraded by analysts at HC Wainwright to a "strong-buy" rating.MarketBeat
JBIO
Earnings
- 11/13/25 - Beat
JBIO
Sec Filings
- 2/17/26 - Form SCHEDULE
- 2/17/26 - Form SCHEDULE
- 2/17/26 - Form SCHEDULE
- JBIO's page on the SEC website